Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Arcadia Biosciences (RKDA) Shares Outstanding (2016 - 2025)

Arcadia Biosciences' Shares Outstanding history spans 12 years, with the latest figure at $1.4 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 0.6% year-over-year to $1.4 million; the TTM value through Dec 2025 reached $1.4 million, up 0.6%, while the annual FY2025 figure was $1.4 million, 0.6% up from the prior year.
  • Shares Outstanding reached $1.4 million in Q4 2025 per RKDA's latest filing, roughly flat from $1.4 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $22.2 million in Q3 2021 to a low of $554609.0 in Q4 2021.
  • Average Shares Outstanding over 5 years is $4.2 million, with a median of $1.4 million recorded in 2024.
  • Peak YoY movement for Shares Outstanding: skyrocketed 146.55% in 2021, then plummeted 97.5% in 2022.
  • A 5-year view of Shares Outstanding shows it stood at $554609.0 in 2021, then grew by 11.08% to $616079.0 in 2022, then soared by 108.63% to $1.3 million in 2023, then increased by 6.19% to $1.4 million in 2024, then increased by 0.6% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for RKDA's Shares Outstanding are $1.4 million (Q4 2025), $1.4 million (Q3 2025), and $1.4 million (Q2 2025).